The European Medicines Agency — which is two thirds funded by the pharma industry according to Transparency International — has published a summary of adverse reactions to the swine vaccines and Tamiflu in Europe up to 13 December 2009.
The Fourth pandemic pharmacovigilance weekly update of reports of adverse reactions up states that “the most frequent adverse reactions that have been reported are non serious and as expected.”
It says that 28 million people in Europe have been vaccinated so far.
From the “limited information received from 7 countries by 22 December 2009, at least 218 pregnant women have been vaccinated.”
It admits that 13 cases of Guillian-Barre syndrome (GBS) and 1 case of Miller-Fischer syndrome in relation to the vaccines have been reported but claims there is evidence that these cases were caused by the vaccine. It argues that these 13 cases are lower than the overall number of cases expected to naturally occur.
However, medical experts have made a clear connection between the swine flu vaccines and GBS, and the UK government even sent neurologists a letter warning them of the likelihood of an increase in GBS cases as a result of the mass swine flu vaccination programme.
To argue that the 13 cases are just part of the overall number of cases expected to occur naturally strongly suggests the notion that the EMEA is more interested in white washing the pharmaceutical industry than in fulfilling its duties.
Hundreds of deaths in connection with the vaccine have been reported to national regulatory agencies in Europe alone.
